CompoAtlas

PHYTOSPAGYRIE N°13 CŒUR ET VAISSEAUX

Food supplement declared in France, declaration No 2018-10-631

PHYTOSPAGYRIE N°13 CŒUR ET VAISSEAUX (HERBIER DU VELAY) is a food supplement declared in France. Status: withdrawn from the market on 19 January 2023. Main ingredients: Juglans regia 600 mg per day, Melilotus officinalis 375 mg per day, Olea europaea 375 mg per day, Crataegus laevigata 150 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
HERBIER DU VELAY
Food business operator placing the product on the market
SAS VECTEUR ENERGY
Status
Withdrawn from the market on 19 January 2023
Form
Bottle
Daily dose
10
Directions for use
Prendre 5 ml (1 cuillère à café) matin et soir, à diluer dans 5 à 10 volumes d'eau. Agiter avant uti
Not recommended (according to the manufacturer)
Pregnant women

Declaration 210248, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Juglans regia L.Parties aériennesMacérât hydroglycériné600 mg
Melilotus officinalis (L.) Pall.Parties aériennesMacérât hydroglycériné375 mg
Olea europaea subsp. europaeaFeuilleMacérât hydroglycériné375 mg
Crataegus laevigata (Poir.) DC.Sommités fleuriesMacérât hydroglycériné150 mg

Additives

E422

Other ingredients

Vitis vinifera L.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

L'emploi du Mélilot est déconseillé aux femmes enceintes.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Olea europaea subsp. europaea
    Read the warning, when it applies and the studies cited

    OLIVE LEAF - OLEA EUROPAEA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you pregnant or breastfeeding (EMA 2017).

    Sources cited by Health Canada (1)
    • EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (EMA 2017).

    Sources cited by Health Canada (1)
    • EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other diuretics (EMA 2017).

    Sources cited by Health Canada (1)
    • EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf

    Known adverse reactions

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur.

    Health Canada monograph dated 19 December 2025

  • Crataegus laevigata (Poir.) DC.
    Read the warning, when it applies and the studies cited

    Hawthorn

    Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.

    Health Canada monograph dated 31 July 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : HERBIER DU VELAY

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “PHYTOSPAGYRIE N°13 CŒUR ET VAISSEAUX (HERBIER DU VELAY): composition and regulation”, https://compoatlas.com/en/supplements/products/210248-phytospagyrie-n-13-c-ur-et-vaisseaux, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line